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MechanismsExposure to biologically active substances such as therapeutic drugs or environmental toxicants can impact bio-
logical systems at various levels, affecting individual molecules, signaling pathways, and overall cellular process-
es. The ability to derive mechanistic insights from the resulting system responses requires the integration of
experimental measures with a priori knowledge about the system and the interacting molecules therein.
We developed a novel systems biology-based methodology that leverages mechanistic network models
and transcriptomic data to quantitatively assess the biological impact of exposures to active substances. Hierar-
chically organized networkmodels were ﬁrst constructed to provide a coherent framework for investigating the
impact of exposures at the molecular, pathway and process levels. We then validated our methodology using
novel and previously published experiments. For both in vitro systemswith simple exposure and in vivo systems
with complex exposures, our methodology was able to recapitulate known biological responses matching
expected or measured phenotypes. In addition, the quantitative results were in agreement with experimental
endpoint data for many of the mechanistic effects that were assessed, providing further objective conﬁrmation
of the approach.We conclude that ourmethodology evaluates the biological impact of exposures in an objective,
systematic, and quantiﬁable manner, enabling the computation of a systems-wide and pan-mechanistic biolog-
ical impactmeasure for a given active substance or mixture. Our results suggest that various ﬁelds of human dis-
ease research, from drug development to consumer product testing and environmental impact analysis, could
beneﬁt from using this methodology.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.Introduction
The exposure of organisms to biologically active substances leads to
complex responses, with the interplay between DNA, RNA, proteins,
and other biological molecules coalescing to deﬁne the cellular phe-
notypes. Investigation of the resulting biological impact to yield
coherentmechanistic insights requiresmethodologies that can leverage
molecular proﬁling technologies that measure systems-wide changes
in thousands of molecular species from a single experiment (e.g.,
transcriptomics, proteomics, or metabolomics). Additionally, these
methodologies must not only identify the individual molecular “mech-
anisms” that are affected, but also coherently take into account theirc. Open access under CC BY-NC-SA licemutual relationships to achieve an interpretation of their combined ef-
fects at a pathway, system, and possibly even phenotypic-level. While
in biology the term “mechanism” can have multiple interpretations,
here we use the term broadly to describe any molecular activity and
combinations thereof, ranging from individual protein abundances
and functions to systems-level processes like cell proliferation.
A variety of approaches that partially address these investigational
requirements have beendeveloped. For example, to derive insight into in-
dividualmechanisms, transcriptomic data describing the differential gene
expressions produced in response to an exposure can be interpreted
in light of pre-deﬁned sets of genes with similar functions or expres-
sion patterns (as deﬁned by external databases, for example MSigDB
(Subramanian et al., 2005)). Methods like Gene Set Enrichment Analy-
sis (GSEA) (Subramanian et al., 2005) or Reverse Causal Reasoning
(RCR) (Catlett et al., submitted for publication; Selventa), which are
based on the enrichment of these sets within the differentially
expressed genes, enable qualitative investigation of experimental data
in light of the statistical enrichment of mechanisms represented by
each gene set, while other methods like Network Perturbationnse.
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assessment of the degree of perturbation of themechanisms. It should
be noted that the RCR and NPA approaches rely on gene sets that are
causally downstream of each mechanism, and thus allow identiﬁcation
(RCR) and quantitation (NPA) of mechanisms that are likely causes of
the measured differential gene expression, rather than their conse-
quences (e.g., as implicitly assumed when activated pathways are
identiﬁed based on the differential expressions of the transcripts
corresponding to their constituting proteins). To gain systems-level
mechanistic insights, ﬁndings for active molecular mechanisms can
be linked to potential systems-level and phenotypic effects using bi-
ological networks comprised of relationships between molecules
and processes (Barabasi et al., 2011; Schadt, 2009). Such biological
networks are available in a variety of public and commercial data-
bases (e.g., Kyoto Encyclopedia of Genes and Genomes (KEGG) Path-
ways) (Kanehisa and Goto, 2000). However, formal methods to
integrate individual mechanistic ﬁndings and network-level rela-
tionships are required to assess the global biological impact of an ac-
tive substance in a mechanistically coherent manner. They can be
guided by the NPA approach that contains a ﬁrst step in this direc-
tion, since it combines the individual mechanisms interconnected
within a biological network into a single aggregated entity for
which the degree of perturbation can be evaluated.
The ability to gain quantitative systems-level mechanistic insight
into the effects of exposure to biologically active substances or other
environmental insults (together referred to as “exposures”) on bio-
logical networks using molecular proﬁling data has a variety of prac-
tical applications, from drug development to consumer safety. For
example, candidate compounds can be screened for their ability to
affect signaling in therapeutically relevant pathways (e.g., inhibition
of cell cycle), or the molecular mechanisms modulated by chemical
exposure can be quantitatively evaluated for their possible associa-
tion with health risk (e.g., induction of DNA damage). Both of these
examples highlight the pressing need to assess the biological impact
of exposure, whether the ultimate goal is therapeutic intervention or
harm reduction. Recently, there has been an increased focus in sys-
tems toxicology on systems-oriented methodologies that emphasize
the understanding of the biological impact of chemical exposures
with increased mechanistic granularity (Bhattacharya et al., 2011;
Committee on Toxicity Testing and Assessment of Environmental
Agents, National Research Council, 2007; Keller et al., 2012). In par-
ticular, a recent report by the US National Research Council Commit-
tee on Toxicity Testing and Assessment of Environmental Agents
advocates for a shift away from toxicological assessment at the
level of apical endpoints and towards deriving systems-level under-
standing of the effects of an exposure on the affected toxicity path-
ways (Bhattacharya et al., 2011; Committee on Toxicity Testing and
Assessment of Environmental Agents, 2007; Keller et al., 2012;
Krewski et al., 2011). In this context, approaches that can leverage
network-level information together with quantitative assessments
of mechanistic effects provide a powerful opportunity to offer true
systems-level insights into the biological impact of an exposure.
Recently, we proposed a ﬁve-step systems-based strategy for
evaluating the impact of biologically active substances (Hoeng
et al., 2012). The strategy suggests deriving systems-level measures
of biological impact by placing measured experimental data in the
context of a priori assembled biological networks and applying a
set of algorithms to assess their perturbations. In particular, it intro-
duces the “Biological Impact Factor” (BIF) as the systems-wide and
pan-mechanistic measure of biological impact, assessed within the
scope of the processes deﬁned by the network models. We have
constructed a collection of network models that objectively de-
scribes the essential biological processes and responses of healthy
lung and cardiovascular tissues, including cell proliferation, various
stress responses, and inﬂammatory processes. Four publications de-
scribing such network models are currently available (Gebel et al.,2013; Schlage et al., 2011; Westra et al., 2011, 2013) (see Table 2,
and Supplementary information – Table S1 and Supplementary File
“S1.zip” for a full list of the network models as well as their content).
In addition, we recently reported on the development of NPA scoring
methods designed to assess the degree of activation of individual or ag-
gregated biological mechanisms in response to an exposure, as well as
the development of companion metrics to quantify the signiﬁcance
and speciﬁcity of the results (Martin et al., 2012).
Here, we extend on our previous work and describe the ﬁrst im-
plementation of a methodology that can be used to assess the im-
pact of exposures at the molecular, pathway, and systems levels
from transcriptomic data. Speciﬁcally, the methodology provides
a uniﬁed and coherent framework for investigating mechanistic ef-
fects at each of these levels of biological granularity within the
boundaries of the processes described by the network models.
This methodology enables the derivation of the BIF, which provides
a measure of the overall biological impact across all network
models. We applied this methodology to quantitatively assess the
biological impact of exposures on a range of mammalian experi-
mental systems, providing evidence for the methodology's validity
and pertinence in the case of single chemicals or complex chemical
mixtures, as well as simple dosing regimens or complex time courses of
treatment and withdrawal. As a validation of the methodology, we
focused on the comparative impact assessment of different exposures
with one another, as well as with measured or known outcomes
associated with each exposure. Speciﬁcally, we evaluated four ex-
periments, including both in vitro and in vivo studies (Table 1;
Materials and methods section): normal human bronchial epitheli-
al (NHBE) cells treated with a cyclin-dependent kinase (CDK)
inhibitor in vitro (CDKI experiment), mice exposed to inhaled
cigarette smoke in vivo (CS experiment), rats exposed to inhaled
formaldehyde in vivo (FA experiment) (Andersen et al., 2010),
and NHBE cells treated with tumor necrosis factor alpha (TNFα)
in vitro (TNF experiment). These experiments were chosen because
they met two main criteria that enabled us to evaluate the perfor-
mance of our methodology. First, they were performed in experi-
mental contexts that matched those used for constructing the
network models (i.e., pulmonary tissues or tissues that approximate
pulmonary biology). Second, in addition to transcriptomic proﬁling
data, each experiment contained measures for additional phenotypic
endpoints that were reﬂected at different levels in the network models
(Fig. 1;Materials andmethods section). This allowed us tomake a direct
comparison of our ﬁndings at the molecular, pathway, and systems
levels to experimentally measured endpoints as an indicator of the va-
lidity of the methodology. The full set of results from our methods for
all four experiments is available in the Supplementary information, as
is the set of all network models used in this study (Supplementary
File “S1.zip” and Supplementary information-Table S1, respectively).
Materials and methods
CDK inhibitor-treated NHBE cells. NHBE cells were treated with the
CDK4/6 inhibitor PD-0332991 to arrest them in G1 phase and then selec-
tively allow them to re-enter the S-phase of the cell cycle (Supplementary
information — Fig. S1) (Fry et al., 2004). Speciﬁcally, NHBE cells (Lonza
Walkersville, Inc.) were cultured in standard growth medium for 24 h,
treated with a non-toxic dose of 1 μM CDK4/6 inhibitor PD-0332991
(Biozol GmbH, Eching Germany) for another 24 h, and thenwashed in ei-
ther standard growthmediumor in the same concentration of CDK4/6 in-
hibitor. These two treatments “cell cycle re-entry” and “G1-arrest” yielded
two distinct cell populations, which were harvested 2 h, 4 h, 6 h and 8 h
afterwashing (3Petri dishes per timepoint). Total RNAwas extracted and
hybridized to Affymetrix U133 Plus 2.0microarrays. Transcriptomics data
are available in ArrayExpress, accession number E-MTAB-1272.
The fraction of cells in S-phase was determined by ﬂow cytometric
assessment (BD FACSCanto II System with Fluidics Cart — Becton
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Fig. 1.Network and scoring hierarchy. The network hierarchy is composed of HYP, subnetwork, and network, while the scoring hierarchy also includes the BIF level (an aggregation across
a collection of networks). HYPs form the basis of the scoring hierarchy and their scores are computed from differential expression of their downstream gene nodes. Subnetworks are com-
posed of nodes,many ofwhich are HYPs, connected by causal relationships (edges). Subnetwork scores are computed from the scores of their constituentHYPs. Networks are a structured
group of subnetworks that together deﬁne distinct cellular functions. Network scores are computed from their subnetwork scores. The Biological Impact Factor (BIF) is the highest level of
aggregation, and represents the overall biological impact as mechanistically assessed by the networks' score.
Table 1
Experiments used in this study. Data sets from four experiments were used in this study to evaluate the scoring methodology.
Identiﬁer Tissue type Experiment type Treatment
E-MTAB-1272 (Belcastro et al., 2013) Human lung epithelium (NHBE) In vitro 1 μM CDK4/6 inhibitor for 24 h, followed by 2, 4, 6, and 8 h washout
E-MTAB-1313 Mouse lung In vivo 1, 2, 3, 4, 5, and 6 month cigarette smoke (CS)
1, 2, and 3 month CS + 1, 2, and 3 month cessation
GSE23179a Rat nasal epithelium In vivo 0.7, 2, 6, 10, 15 ppm formaldehyde (FA) for 1, 4, and 13 weeks
E-MTAB-1312
Human lung epithelium (NHBE) In vitro 10, 100 ng/ml TNF for 0.5, 2, 4, and 24 h
E-MTAB-1027b
a Andersen et al. (2010).
b Martin et al. (2012).
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Pharmingen™). See Supplementary information for additional details.
Cigarette smoke-exposed mice. Female ApoE−/−mice aged 8–12 weeks
were exposed to fresh air for 6 months, mainstream smoke from the
reference cigarette 3R4F (Tobacco Research and Development Cen-
ter, University of Kentucky, KY, USA) for 6 months, or for 3 months
followed by fresh air for 3 months (Supplementary information —
Fig. S3). Between 6 and 8 mice from each treatment group were eutha-
nized at one-month intervals, 15 to 20 h after the last exposure. The
whole left lung was collected for each mouse, homogenized, and total
RNAwas extracted and hybridized to Affymetrix GeneTitan:GeneChip®
HT MG-430 PM. HT Array plates were scanned using the GT Scanner.
See Supplementary information for additional details. Transcriptomics
data are available in ArrayExpress, accession number E-MTAB-1313.
Bronchoalveolar lavage ﬂuid (BALF) was collected from 8mice from
each treatment group at the 6-month time point, 24 h after the last
exposure. Cell numbers in BALF were determined by ﬂow cytometry
(FACSCanto, BD Biosciences, San Jose, CA, USA). Multianalyte proﬁl-
ing was performed on cell-free BALF supernatants by Myriad RBM
(RBM; Austin, TX, USA) using a multiplexed bead array according
to the RodentMAP v 2.0 program.
TNF-treated normal human bronchial epithelial cells. NHBE cells were
treated with TNFα as previously described (Martin et al., 2012). These
transcriptomic data (deposited in ArrayExpress, accession number E-
MTAB-1312) represent an experimental repeat of a previous data set
(E-MTAB-1027). Both data sets will be used together to assess the
effects of experimental variability on the methods. Brieﬂy, cells were
treated with vehicle control (HBSS) or TNFα (10 ng/mL or 100 ng/mL)
in vitro for 30 min, 2 h, 4 h, or 24 h. Cells were divided into three
technical replicates, and total RNA was extracted and hybridized to
Affymetrix U133 Plus 2.0 microarrays.
Data processing and algorithm implementation. Data processing and
scoring methods were implemented in the R statistical environment
(R Core Team, 2013). Raw RNA expression data were analyzed using
the affy and limma packages of the Bioconductor suite of microarray
analysis tools available in the R statistical environment (Gentleman
et al., 2004). Robust Multichip Average (RMA) background correction
and quantile normalization were used to generate probe set expression
values (Irizarry et al., 2003). For each data set, an overall linear model
was ﬁt to the data for all groups of replicates, and speciﬁc contrasts of in-
terest (comparisons of “treated” and “control” conditions)were evaluated
to generate raw p-values for each probe set on the expression array. Probe
sets were matched to genes (and thus RNA abundance nodes in the
Selventa Knowledgebase; see Supplementary information) by selecting
the probe set in each contrast with the lowest raw p-value for each gene.
Network models. In this study, we used a collection of manually cu-
rated networkmodels that have been assembled to provide anobjective
description of the essential biological processes operating in healthy
lung tissue (Table 2, Supplementary information — Table S1 and File
S1). The network models were constructed using the Biological Expres-
sion Language (BEL), a language for representing scientiﬁc ﬁndings in
the life sciences in a computable form (Selventa, 2012).
Although the biological processes mentioned above are highly
interconnected, the underlying biological mechanisms have been or-
ganized into distinct network models with deﬁned boundaries to ex-
plicitly capture the cellular signaling pathways in each process. This
segmentation enables the independent evaluation of each process
that contributes to a distinct function within the cell. In the scoring
methodology described here, these network models can be envisioned
as an interconnected hierarchy, with each top level network organized
into subnetworks (Fig. 1). The signaling events within each subnetwork
are captured as causal relationships representing signed and directedcause–effect relationships (edges) between biological entities (nodes)
based on experimental evidence reported in primary literature (Supple-
mentary information — Knowledgebase). Because proteins and interac-
tions are often involved in regulating multiple responses, many nodes
and edges are shared among multiple subnetworks, providing an ex-
plicit representation of the interactions between subnetworks. At the
base of the networkmodel hierarchy are nodes that describe individual
molecular mechanisms and that, within the Selventa Knowledgebase,
are causally upstream of gene sets representing increased or decreased
gene expressions that have been observed upon direct experimental
perturbation of the node (Fig. 1). These nodes together with their
downstream gene expression relationships are called HYPs (derived
from “hypotheses”) (Martin et al., 2012), and form the foundation for
the assessment methodology (see Materials and methods — Scoring
overview section). Approximately 40% of the nodes in all subnetworks
considered herein have downstream gene expressions in the Selventa
Knowledgebase and can thus be evaluated as HYPs. As an example,
the Pulmonary inﬂammation network describes the cellular responses
to proinﬂammatory signals, and comprises 24 subnetworks that de-
scribe the signaling pathwayswithinmultiple cell types. In the Epithelial
proinﬂammatory signaling subnetwork, nodes representing interleukin
1 beta (IL1B) and the activity of one of its receptors IL1R1 are connected
by a signed causal relationship stating that the protein abundance of
IL1B increases the activity of IL1R1, and this relationship is supported
by two literature sources (Sha and Markovic-Plese, 2011; Tominaga
et al., 2000). Edges in each network and subnetwork model were de-
rived from peer-reviewed scientiﬁc literature and annotated with
both experimental context (species, tissue/cell type, etc.) and reference
to its source (Gebel et al., 2013; Schlage et al., 2011;Westra et al., 2011,
2013). The node for the activity of IL1R1 is further connected to a node
representing the activity of TRAF6 (a signalingmolecule downstream of
the IL1B receptor) by another edge stating that the activity of IL1R1 in-
creases the activity of TRAF6, supported by two literature sources (Cao
et al., 1996; Sha and Markovic-Plese, 2011). This pathway continues
through to the transcriptional activity of NF-κB, a central mediator of
the inﬂammatory response in lung epithelial cells. In this example,
IL1B is connected to the transcriptional activity of NF-κB throughmulti-
ple intermediate nodes, each supported by multiple literature sources.
We also included additional signaling pathways that mediate inﬂam-
matory signaling in lung epithelial cells in response to extracellular
cues. In total, 66 of the 106 nodes in the Epithelial proinﬂammatory
signaling subnetwork are HYPs (including IL1B and the activities of
IL1R1, TRAF6 and NF-κB). Thus, the nodes and edges in the Epithelial
proinﬂammatory signaling subnetwork form the basic structure for
assessing the biological modulation of proinﬂammatory signaling
in epithelial cells following experimental perturbation. The resulting
hierarchical structure of the complete Pulmonary inﬂammation net-
work model (and all network models considered herein), consisting
of node/HYP, subnetwork, and network levels (Fig. 1), is leveraged
by the methodology to provide coherence and traceability between
the results at any one level with the results from another level in
the hierarchy (see below).
The networks, subnetworks and HYPs deﬁne a priori the range of
biological responses that can be assessed within a given experiment.
The decision to evaluate or omit any given network or subnetwork
must be justiﬁed based on what processes could possibly be relevant
for any given experiment. Here, we assessed biological impact across
all networks and subnetworks that represented cell types that could
potentially have been present in the experimental sample (Supple-
mentary information — Subnetwork models). For example, in the
CDKI experiment where NHBE cells were exposed to a CDK inhibitor
in vitro, the Macrophage activation subnetwork was not evaluated
since macrophages were not present in the experimental system.
Evaluation of the Macrophage activation subnetwork for this data
set would constitute a violation the designated boundaries for the
subnetwork, which by deﬁnition is relevant only within the context
Table 2
Networks and subnetworks. List of networks, and their constituent subnetworks, used in
this study. The number of nodes, HYP nodes, edges, and downstream gene nodes are
taken from the human version of the networks. See Fig. 1 and Supplementary
information — Subnetwork Models for more information.
Network
(nodes/HYPs/edges/gene nodes)
Subnetwork
Cell cycle
(202/60/325/7′793)
Cell cycle
Regulation of proliferation
(726/300/1′474/12′123)
Calcium
Cell interaction
Clock
Epigenetics
Growth factor
Hedgehog
Hox
Jak Stat
Mapk
Notch
Nuclear receptors
PGE2
Wnt
mTor
Pulmonary inﬂammation
(839/389/1′410/11′545)
Mucus hypersecretion
Epithelial cell barrier defense
Epithelial proinﬂammatory signaling
Neutrophil response
Macrophage mediated recruitment
Neutrophil chemotaxis
Tissue damage
Macrophage activation
Macrophage differentiation
Th1 differentiation
Th1 response
Th2 differentiation
Th2 response
Th17 differentiation
Th17 response
Treg response
Tc response
NK cell activation
Mast cell activation
Dendritic cell activation
Dendritic cell migration to tissue
Dendritic cell migration to lymph node
Megakaryocyte differentiation
Microvascular endothelium activation
Stress
(676/255/1′142/10′563)
Drug metabolism response
Endoplasmic reticulum stress
Hypoxic stress
NFE2L2 signaling
Osmotic stress
Oxidative stress
Apoptosis
(280/87/404/4′637)
Apoptosis-caspase cascade
Apoptosis-ER stress-induced apoptosis
Apoptosis-MAPK signaling
Apoptosis-NFkB signaling
Apoptosis-PKC signaling
Apoptosis-proapoptotic mitochondrial signaling
Apoptosis-prosurvival mitochondrial signaling
Apoptosis-TNFR1/Fas signaling
Apoptosis-TP53 TS
DNA damage
(272/63/387/6′250)
DNA damage-components affecting TP53 activity
DNA damage-components affecting TP73 activity
DNA damage-components affecting TP63 activity
DNA damage-DNA damage to G1/S checkpoint
DNA damage-DNA damage to G2/M checkpoint
DNA damage-double-strand break response
DNA damage-inhibition of DNA repair
DNA damage-NER/XP pathway
DNA damage-single-strand break response
DNA damage-TP53 TS
Table 2 (continued)
Network
(nodes/HYPs/edges/gene nodes)
Subnetwork
Necroptosis
(69/24/91/2′245)
Necroptosis-Fas activation
Necroptosis-proinﬂammatory mediators
Necroptosis-RIPK/ROS mediated execution
Necroptosis-TNFR1 activation
Autophagy
(128/43/185/6′481)
Autophagy-ATG induction of autophagy
Autophagy-autophagy induction
Autophagy-mTOR signaling
Autophagy-protein synthesis
Senescence
(317/155/407/7′524)
Senescence-oncogene induced senescence
Senescence-regulation by tumor suppressors
Senescence-replicative senescence
Senescence-stress induced premature senescence
Senescence-transcriptional regulation of the SASP
867T.M. Thomson et al. / Toxicology and Applied Pharmacology 272 (2013) 863–878of macrophage cells. Including all networks and subnetworks that are
potentially relevant to the experiment provides an objective framework
for assessing biological impact of an exposure.
Scoring overview. We built upon a previously described method,
Network Perturbation Amplitude (NPA), for assessing the degree of
exposure-inducedperturbations in biological entities from transcriptomic
data (Martin et al., 2012). NPA scoring uses the relationshipswithin aHYP
to produce a score representing the change in abundance or activity of the
corresponding individual or aggregated entity based on the magnitude
and direction of expression changes of the downstream genes in the
HYP (see below and Supplementary information — HYP scoring). We ex-
tended this method to produce scores for the changes in activity of possi-
bly overlapping subnetworks andnetworks, andultimately an aggregated
score of pan-mechanistic and systems-wide biological impact, the Biolog-
ical Impact Factor (BIF).
The methodology, which is described in detail in the following
sections and the Supplementary information, takes as inputs the dif-
ferential gene expressions obtained for the set of contrasts (e.g.,
treated vs. control comparisons) to be evaluated and a collection of
hierarchically structured network models that provide a coherent a
priori description of the possible responses captured in the experi-
ment. The methodology then integrates the differential gene expres-
sion data with the network models to produce a set of HYP,
subnetwork, network and BIF scores for each contrast (Fig. 1). Nota-
bly, the scoring process was designed to provide complete coherence
and traceability between the results at different levels in the scoring
hierarchy, enabling drill-downs from one level of resolution to the
next following the hierarchical structure of the networks (Fig. 1).
The scoring process thus enables mechanistic insights to be derived
by linking individual effects assessed at different levels of resolution,
providing amulti-scale view of the response of the biological system.
HYP scoring. We used a modiﬁed version of the GPI (Geometric Per-
turbation Index) formula, and the accompanying Uncertainty and Spec-
iﬁcity statistics, to score HYPs (Martin et al., 2012). GPI computes the
mean treatment-induced differential expression of the genes included
in the HYP, where the differential expressions are adjusted for their
expected direction of change and the p-value of the differential expres-
sion:
GPI ¼
X
i
wi 1−pið Þβi; wi ¼
di
N
ð1Þ
where βi is the differential expression of the downstreamgene i, pi is the
raw p-value associated with this difference and obtained using the t-
statistic, di ∈ {−1, +1} is a direction associatedwith the predicted reg-
ulation, andN is the number of downstreamgenes in theHYP. A positive
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a zero GPI score indicates that the process is unchanged, and a negative
GPI score indicates that the process is downregulated. The previously
described GPI algorithm used the false discovery rate-adjusted p-
values, whereas here we used the raw p-values because the p-values
were not used in amultiple hypothesis testing scenario (Supplementary
information — HYP scoring). In addition to computing score conﬁ-
dence intervals that reﬂect the variability across replicates, we also
computed the Speciﬁcity statistic as a measure of whether a score
is speciﬁc to the genes represented by that HYP (Martin et al.,
2012). For example, a score that indicated a two-fold increase in a
given process holds less meaning if all measurements in the entire
data set also increased two-fold. Speciﬁcity is computed by assessing
the likelihood of the following null hypothesis: “The amplitude score
is not representative of the speciﬁc HYP, but instead is representative
of a general trend in the data set that can be measured by any HYP
that is comparable to the HYP of interest” (Martin et al., 2012). Scores
that have Speciﬁcity p-values less than 0.05 are considered to be scores
that can be attributed with high conﬁdence to the HYP of interest.
Subnetwork scoring. The structure of each subnetwork was used to
guide aggregation of the node HYP scores into a subnetwork score
representing a change in the process described by the subnetwork. In
this context, the subnetwork score represented the mean HYP score in
that subnetwork, where each HYP score was adjusted based on the
signed relationships linking the HYP to the rest of the nodes in the
subnetwork. For example, positive scores for HYPs that are inhibitors
of a pathway would provide evidence for a decrease in the pathway ac-
tivity, aswould negative scores for HYPs that are positive regulators of a
pathway. These expectations are encoded by the signed relationships
linking each HYP to the rest of the nodes in the subnetwork, and can
thus be automatically extracted and used to adjust the signs of the con-
tributions of each HYP to the subnetwork score. The subnetwork scores
were thus computed as:
Scoresubnet ¼
X
j
wj dj GPI j ð2Þ
where GPIj is the GPI score for the jth HYP, dj ∈ {−1, +1} is the direc-
tion associated with the relationship between the HYP and the other
nodes in the subnetwork, and wj ∈ [0,1] is the relative contribution
(weight) of the jth HYP (see below and Supplementary information —
Subnetwork scoring). To enable the direct calculation of the Speciﬁcity
statistic and conﬁdence intervals (Martin et al., 2012), we casted the
subnetwork score as a direct function of the underlying gene expression
changes, creating a so-called subnetwork HYP (Supplementary
information — Subnetwork scoring).
The process of aggregating the HYPs in a subnetwork into a full
subnetwork HYP requires that the subnetwork be causally consistent
(called a “balanced graph” in graph theory), meaning that the net causal
relationship between any two nodes in the subnetwork is independent
of the path traversed between the nodes. Of the 77 subnetworks used in
this study, 52 were causally consistent and 25 were causally inconsis-
tent (Supplementary information— Table S1). For 19 of the causally in-
consistent subnetworks, we manually removed between one and six
edges (generally less than 5% of total edges) prior to scoring to make
these subnetworks causally consistent, while still preserving the
biological integrity of the subnetwork (Supplementary information —
Subnetwork scoring). For example, in the TH17 differentiation sub-
network, the transcriptional activity of STAT3 leads to increased expres-
sion of its own inhibitor SOCS3 and this negative feedback loop is an
example of a causal inconsistency. We chose to remove the edge that
leads to increased expression of SOCS3 to eliminate the causal inconsis-
tency and still capture the fact that SOCS3 is a negative regulator of
STAT3. The remaining six causally inconsistent subnetworks were too
complex to resolve manually, so we used a novel algorithm to analyzethe subnetwork structure and produce signed weighting factors
between−1 and 1 for each node,which indicated themost likely direc-
tion of the nodewith respect to the rest of the subnetwork (Supplemen-
tary information— Subnetwork scoring).We validated this algorithm by
applying it to the 19 causally inconsistentmodels that could be resolved
manually and comparing the results with our manual modiﬁcation
(Vasilyev et al., submitted for publication). The sign of these weighting
factors were used as direction coefﬁcients di when aggregating node
HYPs to compute a subnetwork score, and the magnitudes were incor-
porated with other contributions (below) into the weights wj.
Many nodes (including HYPs) are shared among a number of sub-
networks, leading to interdependences between subnetwork scores,
a decreased ability of these scores to capture the biology speciﬁcally
perturbed in a given subnetwork, and ultimately interfering with our
ability to derive speciﬁc mechanistic insights. To reduce the effects of
such overlaps, we modiﬁed the aggregation process to adjust the
contribution wj of each HYP based on how speciﬁc it was to that
subnetwork (Supplementary information — Subnetwork scoring).
Thus, HYPs that were more speciﬁc to a subnetwork had a higher in-
ﬂuence on the subnetwork score than promiscuous HYPs that are
found in many subnetworks (and therefore provide less information
about the modulation of any particular subnetwork). For example, a
node representing the transcriptional activity of NF-κB is found in 17
of the 77 subnetworks, suggesting that while the activity of NF-κB
may be important for many different processes, it does not provide
any signiﬁcant information about which of these 17 subnetworks
are active. While the Megakaryocyte differentiation subnetwork con-
tains this NF-κB node, it also contains a node representing the tran-
scriptional activity of GATA1, which is not found in any other
subnetwork. The transcriptional activity of GATA1 is thus much
more indicative of the activation of theMegakaryocyte differentiation
subnetwork than the transcriptional activity of NF-κB.
Network scoring. Network scoreswere computed by aggregating sub-
networks based on the relationship of each subnetwork to the overall
process represented by the network (Supplementary information —
Table S1). For example, each subnetwork in the Pulmonary inﬂammation
network represents ameasure of increased inﬂammation, and thus each
contributes positively towards the Pulmonary inﬂammation network
score, with the exception of the Treg response subnetwork, which re-
duces overall inﬂammation and thus contributes negatively towards
the network score. In this context, the network score represented the
mean subnetwork score in that network, where each subnetwork
score was adjusted based on the relationship between the subnetwork
and the network:
Scorenet ¼
X
k
wk dk Score
subnet
k ð3Þ
where Scoreksubnet is the score for the kth subnetwork, dk ∈ {−1, +1} is
the relationship of the kth subnetwork with the network itself, and
wk ∈ [0,1] is the relative contribution (weight) of the kth subnetwork
(see below and Supplementary information — Network scoring). To en-
able the direct calculation of the Speciﬁcity statistic and conﬁdence in-
tervals (Martin et al., 2012), we cast the network score as a direct
function of the underlying gene expression changes, creating a so-
called network HYP (Supplementary information — Network scoring).
By design, all subnetworks within a given network represent closely
related biological processes, and thus a simple average of subnetwork
scores as described above would overweight areas of common biology
(e.g., common transcription factors that participate in multiple subnet-
works in a network). The overlaps between subnetworks that were not
fully resolved by down-weighting the effects of promiscuous HYPs (see
above) would lead to a loss of speciﬁcity and mechanistic insight. Thus,
to account for the remaining overlaps, the relative contribution wk of
each subnetwork score was adjusted based on the similarities
869T.M. Thomson et al. / Toxicology and Applied Pharmacology 272 (2013) 863–878(correlation) of each subnetwork HYP (Supplementary information —
Network scoring). This process provided the highest weight to unique
subnetworks, and lower weights to subnetworks that were similar to
other subnetworks.
Biological impact factor (BIF) scoring. The networks represent func-
tionally distinct biological processes characterizing the systems under
consideration. To objectively evaluate overall biological impact without
requiring a priori determination of the relative importance and expected
contribution of each network, we deﬁned the BIF as the sum of the
unsigned perturbations measured in each network. Thus, BIF scores
were computed as themean of the absolute value of the network scores:
BIF ¼
X
l
wl Score
net
l

 ð4Þ
where Scorelnet is the score for the lth network andwl its relative contri-
bution (see Supplementary information— BIF scoring). During the score
aggregation process, network scores were therefore weighted based on
the similarities (correlation) of each network HYP. Because the scoring
procedure is piecewise-linear, BIF score conﬁdence intervals were
estimated via Monte-Carlo sampling from the network score conﬁ-
dence intervals, accounting for the covariance between network
scores due to shared HYPs and their downstream genes (Supplemen-
tary information— BIF scoring). Speciﬁcity is not applicable to the BIF
score because, as a measure of overall impact, there is no expectation
that this score should be speciﬁc to a particular set of genes underly-
ing the BIF score.
Results
CDKI experiment
In the ﬁrst application of the methodology, we used a cell culture
experiment where NHBE cells in culture were allowed to re-enter
the cell cycle after G1-arrest induced by exposure to a small molecule
CDK4/6 inhibitor (CDKI experiment). Re-entry of the cell cycle was
experimentally conﬁrmed by labeling of S-phase cells at 2, 4, 6 and
8 h after CDKI washout. We computed scores for nine networks,
comprised of 57 subnetworks, that matched the cell types present
in cultured NHBE cells in vitro (see Supplementary information —
Subnetworkmodels and Table S1).We compared transcriptomic proﬁles
of cell populationswhere the CDKI had beenwashed out of themedia to
those continuously exposed to CDKI, and used the network, subnetwork
and HYP scores at each time point to identify processes and mecha-
nisms that were differentially activated upon CDKI washout.
Overall BIF scores increased across the washout window, consistent
with the experimental observation of increased number of cells in S-
phase over time (Fig. 2). While several networks had scores that met
speciﬁcity cutoffs at multiple time points, the scores for the Cell cycle
network showed the highest amplitude of increase at all four CDKI
washout time points and the largest contribution to BIF score (even
when accounting for the different weighting factors applied to the
scores for each network; Supplementary information — BIF scoring)
(Fig. 2). Network scores for the Cell cycle increased with washout
time from 2 to 8 h, paralleling the observed increase in S-phase
cells over time with a Spearman correlation coefﬁcient equal to 1
(Fig. 2, Supplementary information — Fig. S2). We then leveraged the
hierarchical structure of the scoring methodology to investigate scores
for the underlying HYPs contributing to the Cell cycle subnetwork
score (the sole subnetwork in the Cell cycle network; see Table 2).
When evaluated in the context of the Cell cycle subnetwork, scores for
HYPs with proximal mechanistic connections to the experimental per-
turbation (CDK4/6 inhibition) showed patterns consistent with cell
cycle re-entry. Speciﬁcally, HYP scores for the abundance or activity of
positive regulators of S-phase entry were observed to increase acrossthe washout window, including the E2F family of transcription factors,
cyclin D1 (CCND1) and the cyclin dependent kinase 4 (CDK4). HYP
scores decreased for the abundance or activity of negative regulators
of S-phase, including retinoblastoma protein (RB1) and cyclin-
dependent kinase inhibitor 1 (CDKN1A) (Fig. 2). Interestingly, scores
for the Regulation of proliferation network were low and remained rela-
tively unchanged across the experimental window (see Discussion
section).
In this experiment, the assessed biological impact of CDKI washout
on NHBE cells displayed the expected time-dependent pattern of re-
sponse. Moreover, our methodology also identiﬁed cell cycle as the pri-
mary process that was perturbed, and this ﬁnding was supported by
many individual HYPs that were consistent with the release of CDK4
and CDK6 from inhibition.
CS experiment
We next applied our methodology to mechanistically assess the
biological impact of a complex perturbation of an in vivo system. In
this experiment, ApoE−/− mice were treated with cigarette smoke
(CS) for 3 months, after which they were either exposed to CS for an-
other 3 months (CS mice), or exposed to fresh air for 3 months (Cessa-
tion mice). This study was IACUC compliant. Whole lung samples from
CS and Cessation mice were compared with Control mice that were
exposed only to fresh air for 6 months (Supplementary information —
Fig. S3). In addition to gene expression collected at onemonth intervals,
various other phenotypic endpoints (including histopathological
parameters as well as multiple analyte levels in the bronchoalveolar
lavage ﬂuid (BALF)) were measured at the 6-month time point,
enabling validation of multiple network, subnetwork and HYP scores
(see below). We scored nine networks, comprised of 77 subnet-
works that were relevant to whole lung tissue (see Supplementary
information — Subnetwork models and Table S1). The network,
subnetwork and HYP scores at the 6-month time point (where
the phenotypic endpoints were measured) were used to identify
processes and mechanisms that displayed different levels of activity in
CS mice and Cessation mice compared with control.
The BIF scores for Cessationmicewere signiﬁcantly lower than those
for continued CS exposure (p b 0.05; Fig. 3), as might be expected
following the removal of a complex stimulus comprised of thousands
of individual chemicals (Rodgman and Perfetti, 2013). We next looked
at the network scores to identify which biological processeswere sig-
niﬁcantly perturbed by cigarette smoke. Scores from the Necroptosis
(necroptosis refers to the programmed form of cellular necrosis), Cell
cycle, and Pulmonary inﬂammationnetworkswere the primary contribu-
tors to the BIF score (Fig. 3).
We were able to corroborate the scores for the Cell cycle and
Pulmonary inﬂammation subnetworks using phenotypic endpoints
measured at the 6-month time point. Speciﬁcally, the scores showed a
statistically signiﬁcant (p b 0.05) decrease in pulmonary inﬂammation
and cell cycle progression in Cessation mice compared with CS mice
(Fig. 4). Consistent with these scores, histopathological analysis found
signiﬁcantly less general inﬂammation and epithelial cell hyperplasia
in CS mice compared with Cessation mice (Fig. 4, Supplementary
information — Fig. S4). Additionally, the increased scores for the
Necroptosis network were in agreement with previously published
ﬁndings for airway epithelial cells exposed to CS (Kode et al., 2006;
Kosmider et al., 2011). Experimental measures of inﬂammatory
endpoints enabled direct evaluation of scores for a subset of Pulmonary
inﬂammation network components: three subnetworks (Macrophage
activation, Neutrophil response, and Dendritic cell activation) and 10
HYPs (extracellular ligands in the Macrophage activation subnetwork).
Scores for theMacrophage activation subnetwork suggested a signiﬁcant
increase in macrophages in CS mice at 6 months, and a signiﬁcantly
smaller increase in Cessation mice (Fig. 4). While a statistically signiﬁ-
cant increase in macrophages in the bronchoalveolar lavage ﬂuid
Autophagy
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Fig. 2. Scores andmeasurements for the CDK inhibitor-treated human bronchial epithelial cells (CDKI experiment). Scores were computed using transcriptomic proﬁling data fromNHBE
cells for CDKIwashout comparedwith continued CDKI treatment. Scores for the subnetwork level are not shown because the Cell cycle network consists of only a single subnetwork (with
the same scores as the network). Error bars represent 95% conﬁdence intervals, and scores that failed the Speciﬁcity criterion are colored gray.
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Fig. 3. BIF and network scores for the lungs of cigarette smoke-exposed mice (CS experi-
ment). Scores were computed using whole lung transcriptomic data from mice exposed
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Fig. S3). Error bars represent 95% conﬁdence intervals, and scores that failed the Speciﬁcity
criterion are colored gray.
871T.M. Thomson et al. / Toxicology and Applied Pharmacology 272 (2013) 863–878(BALF) was not observed (Supplementary information — Fig. S5), we
did note a signiﬁcant increase in pigmented macrophages in the tissue
for CS mice, and a signiﬁcantly smaller increase in pigmented macro-
phages in Cessation mice (Fig. 4). The Neutrophil response subnetwork
scores indicated a pattern of increased neutrophil activity, which was
consistent with the increased number of neutrophils in the BALF
(Fig. 4, Supplementary information — Fig. S4). The Dendritic cell
activation subnetwork scores suggested no signiﬁcant change in
the number of activated dendritic cells, which was in contrast to
the experimentally observed increase in dendritic cells in the BALF of
CS and Cessation mice (Fig. 4, Supplementary information — Fig. S4).
This discrepancy can perhaps be understood when considering the
composition of the sample from which the scores were derived
(see Discussion section). The HYP scores in the Macrophage activa-
tion subnetwork were largely consistent with experimental observa-
tions for the 10 HYPs with corresponding ligand measurements
(Fig. 4, Supplementary information— Fig. S4). Speciﬁcally, the scores
indicated a signiﬁcant decrease in levels for six ligands (p b 0.05), and
three of these ligands (colony stimulating factor 2 (Csf2), interleukin-
6 (Il6) and tumor necrosis factor (Tnf)) were experimentally observed
to have a statistically signiﬁcant decrease in the BALF. Although themagnitude and statistical signiﬁcance of some of the results varied
between HYP scores and experimental measurements, the pattern
of response between CS and Cessation mice was similar for all
ligands, with the exception of scores for the Cd40 ligand (Cd40lg)
and interleukin-2 (Il2), which were low and unchanged between
CS and Cessation mice (see Discussion section).
For the CS experiment, the scoring methods produced global BIF
scores that were consistent with our expectations, in particular regard-
ing the separation between the CS and Cessation treatments. Moreover,
the hierarchical structure of the networks was used to gain a mechanis-
tic understanding of the biological impact of the CS exposure, revealing
multiple networks, subnetworks and HYPs whose scores were consis-
tent with measured experimental endpoints.
FA experiment
We further applied our quantitative approach for assessing bio-
logical impact to another complex experiment, where rats were ex-
posed to escalating doses (from 0.7 to 15 parts per million (ppm))
of formaldehyde gas in vivo (FA experiment; GEO accession number
GSE23179) (Andersen et al., 2010). Transcriptomic data from the
nasal epithelium was collected after 1, 4 and 13 weeks of exposure.
The availability of multiple measured phenotypic endpoints repre-
sented by the networks allowed us to use the FA experiment to in-
vestigate the results of our scoring methodology across multiple
biological processes in both a dose and time dependent manner.
This experiment was also used in a previous publication as a prelim-
inary example of the value of mechanistically assessing biological
impact (Hoeng et al., 2012).
Formaldehyde (FA), a known rodent carcinogen and irritant that
strongly induces cross-links and single strand breaks in DNA, causes
dose-dependent tumor formation in rat nasal epithelium upon long
term exposure (Kerns et al., 1983). Under the conditions used here,
nasal FA exposure has been shown to increase regenerative cell pro-
liferation, necrosis and inﬂammation in rats (Andersen et al., 2010).
Although the networks and subnetworks used herewere constructed to
represent biological responses and cell types in the lung (Gebel et al.,
2013; Schlage et al., 2011; Westra et al., 2011, 2013), recent studies in-
dicate that the nasal epithelium and pulmonary epithelium share simi-
lar responses to CS when assessed using transcriptomics (Sridhar et al.,
2008; Zhang et al., 2010). We used 62 subnetworks across nine net-
works where we found sufﬁcient published evidence for the process
or cell type being present in the nasal epithelium (see Supplementary
information — Subnetwork models and Table S1).
Scores for the DNA damage and Cell cycle networks showed high
consistent signal intensity across time points (Fig. 5). Necroptosis,
Pulmonary inﬂammation and Senescence network scores were highest
at early time points (1 week) and decreased with longer exposure.
Scores for the Cell cycle network, and for HYPs for canonical cell cycle
regulators, displayed a time- and dose-dependent pattern consistent
with the observed cell proliferation in the rat nasal epithelium mea-
sured by BrdU incorporation, as quantiﬁed by a Spearman correlation
coefﬁcient equal to 0.75 (Fig. 5, Supplementary information — Fig. S6).
In addition to increased cell proliferation, FA exposure induced necrotic
lesions in the nasal epithelium, with the most pronounced effects
seen at 1-week exposure to higher (6 ppm or greater) concentra-
tions (Fig. 5). In agreement with these measurements, one of the
highest amplitude scores was observed for the Necroptosis network,
where the scores peaked at the highest dose of FA (15 ppm) at
1 week of exposure (Fig. 5). The good overall consistency between
the scores of the Necroptosis network and the necrosis measure-
ments was conﬁrmed by Spearman correlation coefﬁcient equal to
0.69 (Fig. 5, Supplementary information — Fig. S6). Our results for
the Necroptosis network were further conﬁrmed by previous studies
examining the effects of inhaled FA in the rat nasal epithelium,
where necrotic lesions are routinely observed (Abdo et al., 1998;
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872 T.M. Thomson et al. / Toxicology and Applied Pharmacology 272 (2013) 863–878Harman et al., 1997; Ohtsuka et al., 1997). One of the main biological
consequences of cellular necrosis is the induction of a local inﬂammatory
response initiated by the cellular debris and proinﬂammatory molecules
released from necrotic cells (Vandenabeele et al., 2010) Our observation
that scores for the Pulmonary inﬂammation network showed similar acti-
vation patterns to those for theNecroptosis network across dose and time
may indicate the mechanistic linkage of these two processes in this ex-
perimental context aswell (Fig. 5). As expected, in addition to Cell cycle,Necroptosis and Pulmonary inﬂammation networks, the DNA damage
network showed a dose-dependent pattern of activation at all time-
points assayed (Fig. 5). Although DNA damage was not measured di-
rectly in these experiments, FA exposure has been shown to cause a
dose-dependent increase in DNA–protein crosslinks in rat tracheal ex-
plants, respiratory epithelial cells, and olfactory epithelial cells in vitro
(Cosma et al., 1988; Kuykendall et al., 1995), aswell as in rat nasal respi-
ratory epithelium in vivo (Conolly and Andersen, 1993). The DNA
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Fig. 5. Scores and measurements for the nasal epithelium of formaldehyde-exposed rats (FA experiment). Scores were computed from transcriptomic data for rats exposed to 0.7 ppm
(red), 2 ppm (blue), 6 ppm (green), 10 ppm (purple) and 15 ppm (brown) formaldehyde (FA) for 1 week, 5 weeks and 13 weeks compared with time-matched control rats. Necrosis
measurements count the number of animal presenting nasal necrosis/erosion (in samples of eight), Proliferation is measured by BrdU incorporation, and both measurements are com-
pared with time-matched controls. Error bars represent 95% conﬁdence intervals, which were calculated using the standard error of a difference of two means and the Welch–
Satterthwaite equation. Scores that failed the Speciﬁcity criterion are colored gray. Necrosis and Proliferation measurements were taken from the original publication (Andersen et al.,
2010).
873T.M. Thomson et al. / Toxicology and Applied Pharmacology 272 (2013) 863–878damage network scores were largely driven by increased HYP scores for
the transcriptional activity of TP53, the kinase activity of ATM, and the
protein abundance of CDKN1A (not shown). Apoptosis, Stress and Regu-
lation of proliferation network scores met the Speciﬁcity criterion at few
or none of the 15 dose/time point combinations assayed.
In this complex experiment, our methodology meaningfully ex-
tended our preliminary investigation and correctly quantiﬁed the acti-
vation of multiple biological processes, two of which were validated by
external measurements, and the remainder of which were in agree-
ment with previous studies. In addition, network scores for these
processes as well as the overall BIF followed an a priori expected
monotonic dose-dependent pattern of activation.TNF experiment
Experimental variability has the potential to introduce systematic
biases to molecular proﬁling data, even in well-controlled in vitro
studies. These biases in turn, have the potential to inﬂuence the
scores generated by our methodology and subsequent interpretation.
To demonstrate that the results of our approach capture real biological
signal and reduce experimental biases, we used a cell culture exper-
iment consisting of two complete repeats of the same experimental
condition done months apart: normal human bronchial epithelial
cells (NHBE) in culture treated with two doses of TNFα (10 ng/mL
or 100 ng/mL) in vitro for 30 min, 2 h, 4 h, or 24 h (TNF experiment).
874 T.M. Thomson et al. / Toxicology and Applied Pharmacology 272 (2013) 863–878The scores for all HYPs, subnetworks and networks were very similar
across the repeats, with a Pearson correlation coefﬁcient of 0.95 (Sup-
plementary information — Fig. S8). A strong correspondence was also
seen for individual HYPs of interest (Supplementary information —
Fig. S9). In contrast, the Pearson correlation coefﬁcient for the differen-
tial gene expression across repeats was 0.56, suggesting that the scoring
process is able to overcomemuch of the variability, likely through com-
bining the values for multiple genes.
Discussion
The results described here provide a signiﬁcant extension to previ-
ous quantitative methods for scoring networks (Martin et al., 2012)
by integrating transcriptomic data with hierarchically-structured net-
work models representing a large assembly of prior causal knowledge.
Notably, we described a uniﬁed and coherent framework for scoring
biological entities ranging from individual molecular mechanisms to
systems-level processes, as well as methods for computing scores for
each level (Fig. 1). Each of these scores represents an objective as-
sessment of the degree of activation based on the known effects of
that activity, here the differential expression of genes although differen-
tial levels or activities of other biological molecules (for example, pro-
teins) could similarly be used (see below). This work constitutes the
ﬁrst application of our novel quantitative methodology that provides
comprehensive mechanistic insights into the biological response to
exposures measured by transcriptomics (Hoeng et al., 2012). One
envisioned utility of this methodology is to provide a comparative
assessment of the biological impact of different therapeutic agents
to understand their relative effects on a range of biological processes
(including both therapeutically relevant and irrelevant processes).
Furthermore, the biological impact of environmental exposures or
consumer products could be assessed as a novel approach for sys-
tems toxicology. Such applications would represent a signiﬁcant ad-
vancement for next-generation systems toxicology, consistent with
the US National Research Council and others who have advocated
for a shift towards credible and defensible approaches for assessing
toxicological impact at the network level (Bhattacharya et al., 2011;
Committee on Toxicity Testing and Assessment of Environmental
Agents, 2007; Keller et al., 2012; Krewski et al., 2011).
Evaluation of the methodology
We applied our quantitative approach for assessing biological im-
pact to four distinct experiments and found that the results were
consistent with expected or measured phenotypic responses in
each experiment. Using a collection of hierarchically structured bio-
logical networks, we were able to place the results into the context of
known biological signaling. This unique property of our approach of-
fers the ability to obtain quantitative measure of the impact of expo-
sures at multiple levels of biological resolution.
In the ﬁrst experiment that we considered, where cell cycle re-entry
was induced in NHBEs, we compared scores for networks, subnetworks
and HYPs to measured phenotypes. Chemical inhibition of CDK4 and
CDK6 disrupts the interaction of these kinases with cyclin D family
members, preventing formation of the active complex required for
downstream signaling to E2F and RB transcription factors and progres-
sion through the cell cycle from G1 to S phase (Fry et al., 2004). Our
methodology was able to identify activation of the cell cycle as the
main biological processmodulated following release of cell cycle inhibi-
tion. Stepping through the network hierarchy to elements within the
Cell cycle subnetwork, scores for HYPs with proximal mechanistic con-
nections to the experimental perturbation, including CCND1 and E2F
family members, followed expected trends (Fig. 2). The contribution
of the Regulation of proliferation network to the BIF score was negligible
across all time points, which is consistentwith the fact that the proteins
in the core cell cycle machinery (CDK4/6) were directly targeted by theCDK inhibitor, while the inhibitor did not act on proteins in the periph-
eral pathways described by the Regulation of proliferationnetwork (such
as growth factor signaling).
For the CS experiment, network and subnetwork scores for
necroptosis, cell cycle and pulmonary inﬂammation were signiﬁ-
cantly increased by CS exposure. The increased necroptosis score in
response to CS exposure is consistent with previous ﬁndings for airway
epithelial cells (Kode et al., 2006; Kosmider et al., 2011), and direct
measures of epithelial cell hyperplasia and pulmonary inﬂammation
were consistent with scores from the Cell cycle and Pulmonary inﬂam-
mation networks, and the Macrophage activation and Neutrophil re-
sponse subnetworks. We also compared the scores for some of the
HYPs in theMacrophage activation subnetworkwith experimentalmea-
surements; 10 ligands measured in the BALF were HYPs in this model.
With the exceptions of Cd40lg, Il2 and Il10, the same pattern was qual-
itatively similar for all ligands, and the differences lay only in the mag-
nitude and statistical signiﬁcance of the pattern (Fig. 4, Supplementary
information — Fig. S4).
In the FA experiment, our methodology suggested signiﬁcantly
increased necroptosis, cell cycle, pulmonary inﬂammation and DNA
damage in response to FA treatment, consistent with the observa-
tions of the original authors of this study (Andersen et al., 2010), as
well as with previous ﬁndings (Conolly and Andersen, 1993; Cosma
et al., 1988; Kuykendall et al., 1995; Vandenabeele et al., 2010). The
DNA damage network scores were largely driven by increased scores
for the transcriptional activity of Tp53 HYP (not shown). Previous
studies noted the occurrence of loss of function point mutations in
the Tp53 gene in nasal tumors isolated from rats exposed to high
doses (15 ppm) of formaldehyde for up to 2 years (Recio et al.,
1992). Many of these mutations were also found in human cancers
(Caron de Fromentel and Soussi, 1992). The frequent occurrence of
inactivating Tp53 mutants in cancer suggests a strong protective role
for Tp53 in the normal response to formaldehyde exposure (Recio
et al., 1992), consistent with our scores for increased Tp53 activity.
We also noted a reduction in scores at later time points inmultiple net-
works (e.g. Senescence,Necroptosis and Pulmonary inﬂammation), which
may be attributed to an adaptive response of the nasal epithelium to
prolonged irritant exposure. In support of this, the authors of the origi-
nal study characterizing these animals noted increased squamous
metaplasia (an adaptive tissue response) in the nasal epithelium of
rats exposed to high doses of FA for 13 weeks (Andersen et al., 2010).
Altogether, in these three experiments we found that ourmethodol-
ogy was able to identify the major biological processes that were mod-
ulated in a variety of experimental systems. Using a fourth experiment,
which included a complete repeat of an experimental protocol, wewere
able to demonstrate the robustness of themethodology to experimental
variability. These results conﬁrm the utility of our network-basedmeth-
odology formechanistic assessment of biological impact, and support its
promise for further assessment, diagnostic, and even predictive applica-
tions (see below).
Leveraging a priori knowledge
Successful application of the methodology depends on accurate and
detailed a priori knowledge describing the relationships between individ-
ual biological mechanisms (to deﬁne networks and subnetworks), and
between these mechanisms and the downstream genes whose expres-
sion they modulate (to deﬁne HYPs). We used manually curated causal
network models encoded in the Biological Expression Language (BEL,
see Supplementary File “S1.zip”), which provide a high-quality descrip-
tion of the relevant biological processes (Gebel et al., 2013; Schlage
et al., 2011; Westra et al., 2011, 2013). These networks are better suited
for our purpose of comparatively assessing biological impact than, for in-
stance, gene networks reconstructed from transcriptomic data, which are
biased toward their input data and do not guarantee causal connections
between their nodal entities. Additionally, the reliance on broad a priori
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posure?) is advantageous in that it provides an objective framework
againstwhich to evaluate speciﬁc experimental ﬁndings (i.e., whatmech-
anisms were actually affected by an exposure and with which magni-
tude?). While the selection of network boundaries may contain some
subjective elements (including selection of proteins and processes to in-
clude in the network, as well as determining the appropriate experimen-
tal contexts for the valid application of the network), broad boundaries
that are inclusive ofmost signaling expected in healthy lung tissue enable
the inclusionof awide range of signaling events and increase the objectiv-
ity of the results, in particular when evaluated against experimental data
that fall within these network boundaries (e.g., responses of healthy lung
cells to a perturbing exposure) (Gebel et al., 2013; Schlage et al., 2011;
Westra et al., 2011, 2013).
The quality of the scoring results is expected to further increase as we
increase our knowledge and understanding of the connections between
the biological entities of the network, as well as between the subset of
the network nodes that are HYPs and the downstream genes they mod-
ulate. For example, all the network models used in this study (listed in
Table 2 and Supplementary information — Table S1, and available in
Supplementary File “S1.zip”) were constructed with relationships
gleaned from the primary literature (Gebel et al., 2013; Schlage et al.,
2011; Westra et al., 2011, 2013). As further nodal or relational infor-
mation is uncovered or collected from primary experiments, these
network models can be further updated (Iskandar et al., submitted for
publication) and will be made available in a public database (Kleiman
et al., in preparation). Additionally, the scores were computed based on
relationships between the HYP nodes in the networks and the down-
stream gene expressions that they modulate. These relationships (see
Supplementary File “S2.xlsx” for the Cell cycle network) were also
curated from the primary literature as well as public repositories of
transcriptomic data like the Gene Expression Omnibus and ArrayExpress
(Barrett et al., 2013; Parkinson et al., 2011). While all such relationships
were captured in the (proprietary) Selventa Knowledgebase, we are also
fostering a common format for information interchange and supporting
efforts for public dissemination of knowledge via openBEL (e.g., the The
“BEL Large Corpus” (Selventa, 2012, 2013)) and through speciﬁc publica-
tions (Catlett et al., submitted for publication; Martin et al., 2012). These
exchanges are intended to facilitate incorporation of additional knowl-
edge into the HYPs of the network models and thereby be beneﬁcial for
the quality of the scoring results.
An expansion in a priori knowledge can affect the scoring results
in multiple ways. First, reﬁned knowledge of the subnetworks, mo-
lecularmechanisms, and relationships thereinwill increase the spec-
iﬁcity of the scores for individual subnetworks. Second, increasing
the amount of a priori knowledge will enable the construction of
HYPs for entities that were not previously able to be scored and in-
crease the robustness of HYPs supported by a small number of down-
stream gene expression changes, thus increasing overall scoring
sensitivity. Third, reﬁned knowledge about the downstream genes
for individual HYPs will enable us to consider only those genes that
can bemodulated by that HYP in the biological context under consid-
eration (e.g., consider only those genes modulated in lung epithelial
cells by eachHYP in the Cell cycle subnetwork). Because of the hierarchi-
cal structure of this scoring approach, reﬁned a priori knowledge (for
example, reﬁnement of a HYP to contain more downstream gene
expressions from an appropriate context) can increase the quality of
score results at the HYP, subnetwork, network and BIF levels.
In the CDKI experiment, we found that scores for the kinase activity
of CDK4, kaof(CDK4), did not increase with inhibitor washout as
expected and failed to meet Speciﬁcity cutoffs at any time point. Upon
further examination, we noted that the HYP for the kinase activity of
CDK4 contains only ﬁve downstream genes that were measured in
this data set. Producing a robust score from such few genes may be an
optimistic endeavor. Additionally, we were unable to score HYPs for
the abundance or kinase activity of CDK6 because we did not haveany downstream genes associated with either HYP. This type of infor-
mation gap can be addressed as new prior-knowledge derived relation-
ships are uncovered and added to the knowledgebase. For example, an
experimentmeasuring genes that are differentially expressed following
the introduction of a constitutively active form of CDK4 in healthy lung
cells would provide relevant knowledge for the kaof(CDK4) HYP. In
order to avoid situations similar to the kaof(CDK4) HYP, we decided
that admissible HYPs should contain at least four downstream genes.
We preferred choosing a minimum HYP size that is accompanied by a
few unstable score results, rather than rejecting too many small HYPs
and thereby losing the information about the network structure. It is
important to note that because of the abundant prior knowledge else-
where in the highly structured Cell cycle subnetwork, we were still
able to robustly identify perturbation of the cell cycle as themajor effect
of the CDK inhibition.
Finally, although this approach was described with genes as the
downstream entities of HYPs, other data modalities would provide
an alternate data type against which to evaluate which entities and
processes are perturbed. For example, systems-wide proteomic or
phosphoproteomic measurements could be used to compute scores
for HYPs that relate the entity or process of interest to changes in pro-
tein level or phosphorylation (instead of changes in gene expression).
Alternatively, individual proteomic or phosphoproteomic measure-
ments could be used directly as scores for those entities. Combining
scores from multiple data modalities could potentially increase both
the speciﬁcity and accuracy of results.
Interpretation of results in light of experimental context
Interpretation of scoring resultsmust be donewith understanding of
the network boundaries (see above) and the experimental context of
the data. Themethodology is designed to quantify the perturbed biolog-
ical processes that are described by the networkmodels and reﬂected in
the levels ofmRNA isolated from the experimental sample. For example,
scores for the CS experiment suggested no signiﬁcant change in dendrit-
ic cell activity while a signiﬁcant increase in dendritic cells in the BALF
was experimentally observed. However, by absolute number, dendritic
cells comprised a small fraction of the cells in the BALF (4.7%, compared
with neutrophils which comprised 19.1% of cells in the BALF; Fig. 4).
Thus, it is likely that the inability to detect a signiﬁcant score for dendrit-
ic cell activation is a reﬂection of the fact that the mRNA from dendritic
cells in the BALF was sufﬁciently diluted in the whole lung sample. Ad-
ditionally, differences between ligand levels in the BALF (where they
were measured) and in the tissue (where their impact on gene expres-
sionwas used to produce the HYP scores) in the CS experimentmay ex-
plain why scores for Cd40lg, Il2 and Il10 may have differed from
experimental measures (Fig. 4, Supplementary information — Fig. S4).
A direct validation of the cytokine HYP scores would involve knowing
cytokine levels in the whole lung tissue itself. Nevertheless, we pre-
ferred to suitably measure them from the BALF, even if this might in-
duce dilution effects affecting their comparison with scores obtained
from whole lung tissues.
Score speciﬁcity
In order to assess the statistical signiﬁcance of a HYP, subnetwork, or
network score (Eqs. (1)–(3)), we computed its Speciﬁcity statistic
(Martin et al., 2012). This quantity measures whether the score value
is speciﬁc to the downstream genes imposed by the network models
and does not simply reﬂect a general trend of the data, in which case
an alternative choice of downstream genes would give similar score
values. Concretely, the Speciﬁcity calculation compares the actual
score value to a null distribution of score values obtained for suitably
sampled alternative choices of downstream genes assigned to the net-
work models. The associated Speciﬁcity p-value represents the fraction
of alternative choices of downstream genes leading to more extreme
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genes imposed by the network models. At the HYP level, the Speciﬁcity
statisticwas able to distinguish cell cycle-related processes from inﬂam-
matory signaling (Martin et al., 2012). This motivated us to apply the
Speciﬁcity statistic to aggregated subnetwork and network HYPs,
which are aggregated HYPs and contain more information than a “stan-
dard”HYP of the same size, as indicated by the non-uniformweights in-
troduced by Eqs. (2)–(3). As a consequence, the Speciﬁcity statistic of an
aggregated HYP does not only challenge the matching between the
signs di of its downstream edges and the (true positive) differential ex-
pression (1 − pi) βi of the associated genes, but it additionally includes
the relative importance of the downstreamnodeswithin the aggregated
HYP, as determined by their relationships within the subnetwork or
network. In other words, the Speciﬁcity statistic of an aggregated HYP
does not only test the assignment of the downstream genes to the bio-
logical mechanism described by the subnetwork or network models,
but it additionally tests the structure of the subnetwork or networks,
which combines the lower-level processes described by “standard”
HYPs in a unique way.
Since the Speciﬁcity statistic was conceived to quantify the statistical
signiﬁcance of a HYP, subnetwork, or network score, we used it exten-
sively during the development phase of our methodology to help us in
“actively” selecting the approaches that yielded less false positive re-
sults. This concern also incited us to use the modiﬁed GPI HYP scor-
ing involving the weighted (true positive) differential expressions
(1 − pi) βi (rather than βi alone) that reduces the contribution to
HYP scores from the genes that are statistically non-signiﬁcantly dif-
ferentially expressed (Martin et al., 2012). Furthermore, we ac-
knowledged the fact that each network, subnetwork and HYP score
is not computed completely independently; two HYPs may share
overlapping genes that contribute to their scores, and two subnetworks
or networksmay share commonHYPs, or even common signaling path-
ways. For example,wenoted thatHYPs for the transcriptional activity of
Tp53, the kinase activity of Atm, and the protein abundance of Cdkn1a
are shared between multiple subnetworks in the DNA damage network
and were the primary drivers of their scores in the FA experiment (not
shown). We therefore designed the scoring process to account for
overlaps at multiple levels: the DPH method accounts for HYPs that are
shared among multiple subnetworks (see Supplementary information—
Subnetwork scoring), and the network and BIF scoring methods account
for correlations between subnetworks and networks (see Supplementary
information — Network and BIF scoring). These methods were
designed to eliminate the undue inﬂuence of elements that con-
tribute to multiple processes. However, ultimately these overlaps
can be biologically meaningful and cannot be eliminated or
accounted for entirely by computational methods. Thus, detailed in-
terpretation of the scoring results requires careful analysis of the
scores themselves, as well as adequate understanding of the content
of the networks. In the case of the FA experiment, the subnetwork
and HYP scores in the DNA damage network did not provide sufﬁ-
cient resolution to identify which underlying DNA damage pathways
were affected, but did strongly indicate the presence of DNA damage,
as expected.
Comparison with existing methods
Ourmethod provides an assessment of biological impact for individ-
ual biological entities and processes (as deﬁned by HYPs, subnetworks
and networks) while simultaneously integrating these assessments in
the context of hierarchically-structured networkmodels, which provide
a uniﬁed and coherent framework for a mechanistic interpretation of
these scores. Additionally, the basic unit of assessment, the HYP, is a
highly structured gene set relating the abundance or activity of an entity
to downstream effects that result from direct perturbation of this entity
(here, differential gene expression). This deﬁned structure of a HYP en-
sures that each score is computed from downstream effects of an entityor an overall (aggregated) process. In contrast, previous approaches for
assessing the degree of activation of an entity or process from differ-
ential gene expression (Kiyosawa et al., 2010; Loboda et al., 2010;
Subramanian et al., 2005), for instance the gene sets in MSigDB
(Subramanian et al., 2005), employ gene sets and signatures that
can contain genes with a variety of relationships with the entity.
The consistent representation of HYPs compared with gene sets in-
creases the ability to interpret HYP-based scoring results. Further-
more, these previous approaches did not provide a globally
integrated framework for deriving mechanistic insights across mul-
tiple levels of biological resolution (Kiyosawa et al., 2010; Loboda
et al., 2010; Subramanian et al., 2005). As a consequence, although
these methods can evaluate gene sets for individual proteins as
well as for pathways containing these proteins, the lack of an explicit
framework linking these two gene sets can lead to inconsistent re-
sults at different levels of resolution. For example, adding up the con-
tributions of the individual proteins can yield a non-zero signal,
while the pathway remains globally inactive due to cancelation effects
between its proteins. This makes it difﬁcult to derive globally coherent
mechanistic insights. The integration across multiple biological scales
by our methodology increases the transparency, defensibility and ﬂexi-
bility of the approach, enabling not only quantitative butmechanistical-
ly coherent insights to be derived. These and other aspects of our
methodology can be concretely illustrated in the case of the data sets
used in this study (see Supplementary information — Comparison with
standard gene set-based methods and Table S2).
From a graph-theoretical point-of-view, the network models used
by our method correspond to “signed directed graphs”. Such graphs
appear in othermodeling approaches used in Systems Biology, for in-
stance dynamic models using ordinary differential equations (ODE),
in which case the network describes the regulatory relationships be-
tween the different entities of the system. The main particularity of
our approach is the fact that the quantities associated with the net-
work nodes (i.e., the HYP scores) correspond to the amplitudes of
the experimentally-induced perturbation between two experimen-
tal conditions, and can be of any sign (Martin et al., 2012). In con-
trast, absolute or relative molecular concentrations used in ODE-
based modeling of regulatory networks describe the concentrations
at a single point in time, and are always positive (Karlebach and
Shamir, 2008). Another particular aspect of our approach is the ab-
sence of explicit time-dependency in the network models, even
though an implicit “arrow of time” is implied by the causal character
of the edges. An actual time-dependency can be introduced by the
transcriptomic data, in which case consecutive measured time points
provide snapshots of the evolution of the experimentally-induced
perturbation across the HYPs, subnetworks, or networks. Such
time-course experiments could be used in future work to extract
the parameters of an ODE-based description of the underlying regu-
latory network and would constitute a valuable convergence of the
two approaches.
Future applications of the methodology
In this work, we presented a methodology for quantifying the bi-
ological impact of active substances or mixtures and demonstrated
its application using a range of biological and chemical exposures
on in vitro and in vivo systems. As described above, we envision util-
ity of this methodology to provide a comparative assessment of the
biological impact of different therapeutic agents, environmental ex-
posures or consumer products. Furthermore, in addition to applying
this methodology to comparative assessment of the biological im-
pact of different exposures, it could also be applied for hypothesis
generation, for the investigation and diagnosis of disease state, or
even for the prediction of future disease onset.
While in this work we focused on the comparative impact assess-
ment of exposures, scoring results could also be interpreted qualitatively
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describe a coherent biological response that was not expected from a
given experiment can be thought of as novel predictions that could be
veriﬁed or refuted through additional experimental investigation. Simi-
larly, thismethodology could be used for iterative network construction.
Well-controlled experiments like the CDKI experiment can be used to
assess the sensitivity of a subnetwork or network model (in this case,
the Cell cycle subnetwork) to detect the appropriate responses to val-
idate the subnetwork. The same experiment could also be used to
augment the subnetwork by potentially adding to the subnetwork
additional HYPs from the Selventa Knowledgebase (or any other
suitable knowledge source) that are identiﬁed by the methodology
as signiﬁcantly affected by CDKI treatment (similar to the data-
driven model augmentation step from the network building process
(Gebel et al., 2013; Schlage et al., 2011; Westra et al., 2011, 2013)).
As an obvious extension of the comparative assessment of the bi-
ological impact of exposures, the methodology could be applied to
the comparative assessment of disease states. Here, we leveraged a
collection of models that describe the responses of healthy lung
cells (and related tissues) to various exposures. However, it would
be possible to tailor the networks and approach for a particular dis-
ease or experimental context. For example, reﬁned networks could
be constructed to focus on the regulatory signaling in the lungs of in-
dividuals with chronic obstructive pulmonary disease (COPD). These
COPD network models would be more appropriate for evaluating
data from COPD patients as the networks would be tailored to assess
the speciﬁcmechanisms, and interplay betweenmechanism, that are
important for onset and progression of the disease. Additionally, in
the context of a particular disease like COPD, it may be possible to as-
cribe weights to each network based on their individual impact on
overall disease progression or severity. This approach could potentially
be used to produce scores that are tailored for assessing the impact of
various consumer product or environmental factors on COPD severity,
complementing phenotypic measures of disease severity like spirome-
try and imaging (Enright and Kaminsky, 2003; Washko, 2010).
Ultimately, we envision that our methodology could have practical
utility not just for mechanistic disease assessment, as suggested above
for COPD, but also for toxicological assessment and disease risk pre-
diction, as suggested by our preliminary work linking the BIF scores
for FA exposure to tumorigenesis rates in rat nasal epithelial tissue
(Fig. 5, Supplementary information — Fig. S7) (Hoeng et al., 2012).
As described here, a powerful feature of our methodology is the abil-
ity to identify biological mechanisms that are perturbed at multiple
levels of biological resolution following exposure, consistent with a
recent drive to approach toxicological risk assessment at the systems
level (Bhattacharya et al., 2011; Committee on Toxicity Testing and
Assessment of Environmental Agents, 2007; Keller et al., 2012;
Krewski et al., 2011). These mechanisms can be investigated for
their relevance to disease onset. By providing information at a net-
work level, this approach goes beyond the direct mechanism of ac-
tion of an exposure to identify which pathways and processes are
affected. Additional investigation could link these pathways to
mechanisms of disease onset, potentially providing the link between
short term effects and long term disease risks. Moreover, the meth-
odology presented herein also provides information at the molecular
level within the same scoring framework, and this additional level of
granularity can be important for interpreting results, investigating
potential molecular mechanisms of disease onset, and potentially
assessing different alternatives for moderating disease progression.
Extractingmechanistic information frommolecular proﬁling data
remains an ongoing challenge. We developed a network-based scor-
ing methodology that combines experimental molecular proﬁling
data, biological network models and a set of scoring algorithms to
quantitatively infer the perturbations of biological processes modu-
lated by experimental exposures. Using four experiments spanning
a range of experimental complexity, we show that the impactassessed by our approach is consistent with corresponding pheno-
typic measures. In addition, our results highlight a unique feature
of the approach, where the vertically integrated structure of the
scoring methodology can be exploited to investigate scores at multi-
ple levels of biological resolution. Following additional reﬁnement,
we envision future iterations of this approach having utility in a
wide range of commercial and academic settings.
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